In a series comparing the methylation status of BRCA1 among tumor samples obtained from patients with benign ovarian tumors, borderline tumors as well as carcinomas, promoter methylation was detected in 31% of carcinomas but in none of the benign or borderline tumors (35). Here, BRCA1 is linked to carcinoma.